Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
173.45
+13.60 (8.51%)
At close: Oct 28, 2026, 4:00 PM EDT
169.92
-3.53 (-2.04%)
Pre-market: Oct 29, 2026, 7:16 AM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $10.88 billion as of October 28, 2026. It is the 2,003rd most valuable company in the world and the 725th biggest in the United States. Its market cap has increased by 427.19% in one year.
Market Cap
10.88B
Enterprise Value
10.82B
1-Year Change
427.19%
Global Rank
Country Rank
#725 United States
Category
ChartMarket Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $10.88B, an increase of 2,819.58%. That is a compound annual growth rate of 52.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 10.88B | 460.76% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 10.15B |
| Kymera Therapeutics | 9.49B |
| Vaxcyte | 9.44B |
| Corcept Therapeutics | 9.41B |
| Krystal Biotech | 9.23B |
| Caris Life Sciences | 9.18B |
| Protagonist Therapeutics | 9.16B |
| Spyre Therapeutics | 8.79B |